Case Report
Title: Diagnostic Uncertainty in Recurrent Pleural Effusion and Unilateral Lymphedema in an Octogenarian with Chronic Lymphocytic Leukemia and Heart Failure
Keywords: Pleural Effusion, Chronic Lymphocytic Leukemia (CLL), Heart Failure with Preserved Ejection Fraction (HFpEF), Unilateral Lymphedema, Diagnostic Uncertainty, Patient-Reported/Provider-Assisted Medical Journey (PaJR), Team-Based Learning.
Abstract
Diagnostic attribution in geriatric multimorbidity often faces premature cognitive closure. We present an 86-year-old male with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL), heart failure with preserved ejection fraction (HFpEF), and atrial fibrillation who presented with recurrent right-sided multiseptated pleural effusion. The initial diagnostic trajectory attributed the effusion to pulmonary congestion from HFpEF versus empiric tuberculous pleuritis. However, a pivotal caregiver-driven observation—unilateral upper-limb lymphedema—prompted pleural fluid immunophenotyping via flow cytometry, revealing a monotypic clonal mature B-cell population ($\text{CD19}^+$, $\text{CD20}^+$, $\text{kappa-restricted}$). This report constructs a three-layered Patient-Reported/Provider-Assisted Medical Journey (PaJR) framework to analyze the diagnostic uncertainty, balancing competing cardiogenic, lymphogenous, and malignant etiologies through a Socratic steelman methodology.
Introduction
In frail elderly patients with multi-system disease, clinical signs rarely map to a single unified etiology. Recurrent pleural effusion in the presence of underlying CLL/SLL presents a classic diagnostic conundrum: is the fluid accumulation driven by central hemodynamic backup (heart failure), direct pleural infiltration by clonal lymphocytes, secondary lymphatic disruption/chylothorax, or a combination of inflammatory and hydrostatic factors?
Applying the PaJR framework, this case report integrates real-time dyadic caregiver conversations (Layer 1), clinical and academic structuring (Layer 2), and historical trajectory synthesis (Layer 3 ProJR) to demonstrate how participatory medical cognition refines diagnostic accuracy while navigating management dilemmas in advanced age.
Case Presentation (Layer 1 & Layer 2 Integration)
Patient Profile & Baseline History
An 86-year-old male ($\text{86M}$) with a history of CLL/SLL, chronic atrial fibrillation, hypertension, and severe rotator cuff tear presented with progressive fatigue, dyspnea on minimal exertion, lower extremity pedal edema, and recurrent multiseptated right pleural effusion requiring pigtail catheter drainage.
+-----------------------------------------------------------------------------------------+
| TIMELINE OF EVENTS |
+-----------------------------------------------------------------------------------------+
| June 2026 : Initial presentation with fever and dyspnea. Empiric ATT initiated. |
| : Serial discussion re: HFpEF vs. Infectious / Inflammatory etiology. |
| July-Aug 2026 : Persistent pedal edema & breathlessness; diuretic uptitration. |
| : Anemia managed with slow packed RBC transfusion. |
| Sept 03, 2026 : Caregiver identifies unilateral upper-limb lymphedema. |
| Sept 30, 2026 : Pigtail drainage placed for multiseptated, multiloculated effusion. |
| Oct 01, 2026 : Pleural fluid flow cytometry: CD19+, CD20+, Kappa restricted. |
+-----------------------------------------------------------------------------------------+
Diagnostic Trajectory & Pivotal Shift
- Cardiovascular / Hydrostatic Phase: Initial management focused on HFpEF with rate control for atrial fibrillation and diuretic titration ($\text{Torsemide}$ + $\text{Spironolactone}/\text{Furosemide}$). High NT-proBNP supported heart failure, but unilateral/multiseptated features on ultrasound/CT questioned a purely transudative, hydrostatic origin.
- Infectious / Empiric Phase: Empiric anti-tubercular therapy (ATT) was started briefly elsewhere despite negative AFB, GeneXpert, and metagenomic panels, later discontinued after clinical re-evaluation.
- Lymphatic / Hematologic Pivotal Observation: On September 3, 2026, the patient's caregiver highlighted persistent unilateral upper-limb lymphedema. This physical finding directed clinical focus toward systemic lymphatic obstruction or direct lymphomatous involvement.
Laboratory & Diagnostic Investigations
- Pleural Fluid Flow Cytometry (Oct 1, 2026): Identified a clonal, monotypic mature B-cell population:
- $\text{CD19}^+$ positive
- $\text{CD20}^+$ positive (low/variable intensity)
- $\text{Kappa}$ light chain restriction
- $\text{CD10}^+$ heterogeneous
- Echocardiogram: Preserved Left Ventricular Ejection Fraction (LVEF $\ge 50\%$), Left Atrial (LA) dilation, diastolic dysfunction consistent with HFpEF.
- Hemogram: Anemia with Hemoglobin $8.5\text{ g/dL}$, elevated RDW; leucocytosis with persistent lymphocytosis baseline.
Discussion:
To rigorously evaluate the etiology without falling into premature closure, we construct a Socratic dialogue between three clinical viewpoints: The Cardiologist (Hydrostatic hypothesis), The Hematologist-Oncologist (Malignant hypothesis), and The Lymphology/Integrative Internist (Structural/Lymphatic hypothesis).
Socratic Dialogue Matrix
SOCRATIC DIALOGUE MATRIX
┌─────────────────┬─────────────────────────────────────────────────────────────┐
│ PERSPECTIVE │ CORE ARGUMENT & EVIDENCE │
├─────────────────┼─────────────────────────────────────────────────────────────┤
│ Cardiologist │ "The patient has AF, LA enlargement, pedal edema, and │
│ │ elevated NT-proBNP. Fluid retention resolves with diuretics.│
│ │ HFpEF is the principal driver." │
├─────────────────┼─────────────────────────────────────────────────────────────┤
│ Oncologist │ "Flow cytometry confirms CD19+/CD20+/Kappa-restricted cells.│
│ │ This is direct pleural infiltration by B-cell lymphoma." │
├─────────────────┼─────────────────────────────────────────────────────────────┤
│ Integrator │ "Unilateral lymphedema points to structural lymphatic │
│ │ disruption. The effusion is multifactorial—cardiac pressure │
│ │ meets compromised lymphatic clearance." │
└─────────────────┴─────────────────────────────────────────────────────────────┘
Dialogue
- Socrates: If the effusion were purely cardiogenic (HFpEF), why would it present as multiseptated, multiloculated, and refractory to routine decongestive therapy?
- Cardiologist (Steelman): Pleural effusions in HFpEF are usually bilateral or right-sided transudates. However, underlying mild chronic inflammation or previous interventions can cause septations. Still, hydrostatic pressure shifts remain the easiest volume component to treat safely in an 86-year-old.
- Oncologist (Steelman): The presence of a monotypic B-cell population with kappa restriction directly inside the pleural fluid proves clonal lymphomatous involvement. It cannot be dismissed as passive blood contamination if the phenotypic intensity and cell counts are significantly elevated.
- Integrator (Steelman): We must avoid binary thinking. The unilateral upper-limb lymphedema signals impaired systemic lymphatic transport. Lymphatic drainage from the pleural cavity via the thoracic duct and right lymphatic duct is compromised. High central venous pressure from HFpEF further opposes lymphatic return into the subclavian veins, compounding fluid sequestration.
Thematic Analysis of Diagnostic Uncertainty
A inductive thematic analysis of the conversational decision support system (CDSS) logs identified three primary themes governing clinical reasoning in this case:
+-----------------------------------------------------------------+
| THEMES IN DIAGNOSTIC UNCERTAINTY |
+-----------------------------------------------------------------+
| |
| Theme 1: Diagnostic Anchoring vs. Cognitive Pivoting |
| - Initial anchor: Heart failure & TB |
| - Pivot: Caregiver photo/video of unilateral upper-limb edema |
| |
| Theme 2: Multi-causal Convergence (The "Two-Hit" Model) |
| - Hit 1: Elevated hydrostatic filling pressures (HFpEF) |
| - Hit 2: Obstructed pleural lymphatic drainage (CLL/Lymphoma) |
| |
| Theme 3: Frailty-Constrained Management |
| - Aggressive systemic chemo vs. conservative palliative care |
| - Risk of fluid overload with blood transfusions |
+-----------------------------------------------------------------+
Theme 1: Diagnostic Anchoring vs. Cognitive Pivoting
- Analysis: Early dyadic discussions oscillated between Heart Failure (HFpEF) and infectious causes (TB). The unexpected discovery of unilateral upper-limb lymphedema acted as an unanchoring event, shifting focus toward direct malignant infiltration or central lymphatic duct clearance failure.
Theme 2: Multi-Causal Convergence ("Two-Hit" Model)
- Analysis: Pleural fluid absorption depends on functioning parietal pleural lymphatics draining against central venous pressure (CVP).$$\text{Pleural Drainage Rate} \propto \frac{P_{\text{pleural}} - P_{\text{CVP}}}{R_{\text{lymphatic}}}$$In this patient, increased $P_{\text{CVP}}$ (from HFpEF/AF) combined with increased lymphatic resistance $R_{\text{lymphatic}}$ (from malignant lymphadenopathy/infiltration) created a persistent, septated effusion that neither loop diuretics nor pleurocentesis alone could permanently resolve.
Theme 3: Frailty-Constrained Management
- Analysis: Diagnostic clarity does not automatically yield aggressive therapeutic interventions in octogenarians. While systemic chemo-immunotherapy could target the B-cell clone, the patient's severe exhaustion, age (86), and cardiac substrate require a prioritized quality-of-life approach (e.g., intermittent pigtail drainage, cautious low-dose diuresis, symptom-oriented palliative care).
Layer 3 ProJR: Collective Intelligence Integration
Integrating this trajectory with historical ProJR cases ("55F Carcinoma breast, pleural effusion, heart failure" and "Viral fever heart failure in elderly"), we observe a recurring systemic pattern: Diagnostic uncertainty in complex pleural effusions is rarely resolved by a single definitive test; rather, it requires continuous synthesis of caregiver observations, fluid phenotyping, and hemodynamic monitoring.
+-----------------------------------------------------------------------------------+
| THREE-LAYER PAJR ARCHITECTURE |
+-----------------------------------------------------------------------------------+
| LAYER 1: PaJR (Day-to-Day Care Log) |
| - De-identified real-time dyadic caregiver-physician messaging |
| - Captures non-traditional clinical cues (e.g., photo of arm lymphedema) |
+-----------------------------------------------------------------------------------+
| LAYER 2: Structured Clinical Case Report (IMRaD) |
| - Formal academic categorization, laboratory correlation, flow cytometry |
| - Socratic steelman debate & thematic analysis |
+-----------------------------------------------------------------------------------+
| LAYER 3: ProJR (Collective Intelligence Database) |
| - Cross-case trajectory matching with historical database cohorts |
| - Informs decision support algorithms for future multimorbid presentation |
+-----------------------------------------------------------------------------------+
Conclusion & Recommendations
- Acknowledge Multifactorial Etiology: The patient's recurrent pleural effusion is best conceptualized as a combined cardiogenic-lymphatic failure secondary to HFpEF and CLL/lymphomatous involvement.
- Diagnostic Prudence: Flow cytometry showing a monotypic B-cell population confirms pleural space involvement by the known lymphoproliferative disorder, but clinical management must remain guided by patient goals and frailty parameters.
- Role of PaJR: Caregiver-reported observations (Layer 1) provide key directional clues that bridge bedside gaps, driving refined academic structuring (Layer 2) and updating collective clinical intelligence (Layer 3).


No comments:
Post a Comment